Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) have revolutionized the cancer treatment landscape, yet the impact of the timing of the use of an immunosuppressive agent such as steroids on ICI outcomes is poorly described. Utilizing the SEER-Medicare-linked dataset, this study explored the rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikita, Nikita, Banks, Joshua, Keith, Scott W., Song, Andrew, Johnson, Jennifer M., Wilson, Melissa, Sharma, Swapnil, Lu-Yao, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909505/
https://www.ncbi.nlm.nih.gov/pubmed/35267602
http://dx.doi.org/10.3390/cancers14051296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909505/
https://www.ncbi.nlm.nih.gov/pubmed/35267602
http://dx.doi.org/10.3390/cancers14051296

Ejemplares similares